Omega Fund Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Omega Fund Management’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-758,610	Closed	-$660K	–	15
2019 Q2	$660K	Hold	758,610	–	–	0.17%	15
2019 Q1	$1.76M	Hold	758,610	–	–	0.56%	13
2018 Q4	$1.76M	Hold	758,610	–	–	1.3%	13
2018 Q3	$11.2M	Hold	758,610	–	–	5.32%	6
2018 Q2	$11.5M	Hold	758,610	–	–	8.5%	5
2018 Q1	$14.2M	Hold	758,610	–	–	14%	2
2017 Q4	$13.8M	Hold	758,610	–	–	9.96%	3
2017 Q3	$16.9M	Buy	+758,610	New	+$16.7M	9.55%	4

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Omega Fund Management's SNNA Position: Q3 2019 in Review

Omega Fund Management sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 758,610 shares — an estimated $660K sold.

Omega Fund Management first reported a position in SNNA in Q3 2017 and held it in 8 quarters. The position peaked at $16.9M in Q3 2017. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

Omega Fund Management reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Omega Fund Management sold 758,610 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $660K.
Omega Fund Management first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Omega Fund Management's Sienna Biopharmaceuticals, Inc. position peaked at $16.9M in Q3 2017.
23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Omega Fund Management's 13F filing for Q3 2019, filed 13 Nov 2019.